Antimalarial & Antiprotozoal

HydroxychloroquineThird Party Manufacturing in India

Looking to get Hydroxychloroquine manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.

WHO-GMP Certified
Export Ready
PCD Franchise Available
CAS Number
118-42-3
Drug Class
4-Aminoquinoline Derivative / Immunomodulator
Molecular Formula
C₁₈H₂₆ClN₃O
Molecular Weight
335.9 g/mol
Grade Standards
IP, BP, USP
Therapeutic Category
Antimalarial & Antiprotozoal
MOQ
1,000 tablets per batch
Dosage Forms
Tablet

Mechanism of Action

Hydroxychloroquine is a 4-aminoquinoline compound that accumulates in acidic cytoplasmic vacuoles such as lysosomes, where it raises the pH and interferes with antigen processing and presentation. In malaria, it inhibits the polymerization of heme into hemozoin within the Plasmodium parasite, causing toxic accumulation of free heme that kills the parasite. In autoimmune conditions such as rheumatoid arthritis and lupus erythematosus, hydroxychloroquine modulates the immune response by inhibiting toll-like receptor signaling, reducing cytokine production including TNF-alpha and IL-6, and interfering with T-cell activation. This dual mechanism, combining direct antiparasitic activity with immunomodulation, makes it a uniquely versatile therapeutic agent. Unlike chloroquine, hydroxychloroquine has a better safety profile with lower ocular toxicity risk, allowing for longer-term use in chronic autoimmune diseases. It also exhibits antithrombotic and metabolic benefits in lupus patients.

Therapeutic Uses & Indications

Therapeutic Uses

Hydroxychloroquine is prescribed for the treatment of:

  • Malaria: Used for prophylaxis and treatment of uncomplicated malaria caused by chloroquine-sensitive Plasmodium species.
  • Rheumatoid Arthritis: Disease-modifying antirheumatic drug for managing symptoms and slowing disease progression.
  • Systemic Lupus Erythematosus: Reduces lupus flares and prevents organ damage, particularly skin and joint manifestations.
  • Cutaneous Lupus: Treats discoid lupus and other forms of skin lupus.

Why Manufacturers Choose Hydroxychloroquine

Hydroxychloroquine has sustained global demand for both antimalarial and rheumatology applications. Indian manufacturers are well-positioned due to established API supply chains and cost-efficient production capabilities. Its inclusion in the WHO Essential Medicines List and consistent demand from PCD franchise networks make it a strategic addition to any third party manufacturing portfolio. The 200mg tablet format is the standard dosage form globally, ensuring straightforward formulation and packaging.

Dosage Forms We Manufacture

Tablet
200mg

Frequently Asked Questions

What is the minimum order quantity for Hydroxychloroquine?
Minimum order quantity for Hydroxychloroquine is 1,000 tablets per batch. Please contact us for bulk pricing and custom quantities.
What dosage forms of Hydroxychloroquine can you manufacture?
We manufacture Hydroxychloroquine as: Tablet (200mg).
Are your manufacturing facilities WHO-GMP certified?
Yes. Celesta Healthcare works exclusively with WHO-GMP certified partner production facilities. All manufacturing batches are subject to strict quality control and documentation.
Can you manufacture Hydroxychloroquine for export?
Yes. We provide export-ready Hydroxychloroquine formulations structured across 25+ countries. We provide full export documentation including Certificate of Analysis (CoA), Certificate of Origin, and regulatory dossiers on request.
What grade standards do you follow for Hydroxychloroquine?
We manufacture Hydroxychloroquine to IP, BP, USP pharmacopoeial standards.
Third Party Manufacturing

Get Hydroxychloroquine made under your brand

  • WHO-GMP certified facilities
  • Quote within 24 hours
  • MOQ from 1,000 tablets per batch
Get a Manufacturing QuoteWhatsApp Us Now

+91 9689237122 · replies within hours

Our Manufacturing Capabilities

  • WHO-GMP Certified Partner Plants
  • 25+ years of pharma industry experience
  • PCD Franchise with monopoly rights
  • Export support across 25+ countries
  • Small batch to commercial scale
  • Custom formulation development

Packaging Options

Blister pack (Alu-Alu), Strip pack, HDPE bottle. Packaging customized to client brand guidelines.

Start Manufacturing Hydroxychloroquine Today

Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Hydroxychloroquine across all dosage forms. PCD franchise and export orders welcome.

Need something? Chat with us!